AB Science S.A Cash Flow Conversion Efficiency

Latest as of December 2025: 0.021x

AB Science S.A cash flow conversion efficiency. Based on the latest financial reports, AB Science S.A (AB) has a cash flow conversion efficiency ratio of 0.021x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-207.00K ≈ $-242.00K USD) by net assets (€-9.81 Million ≈ $-11.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of AB Science S.A (2009–2025)

Cash flow conversion efficiency of AB Science S.A from 2009 to 2025. This chart illustrates how AB Science S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AB Science S.A stock price for real-time trading data and today's change.

AB Science S.A Cash Flow Conversion Ratio Explained

AB Science S.A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

AB Science S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AB Science S.A ranked by their cash flow conversion efficiency. Also see AB market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Marine & General Bhd KLSE:5078	0.432x
Yonyu Plastics Co Ltd TW:1323	0.013x
Gseven Co Ltd TWO:2937	0.104x
Hai Phong Hoang Ha Paper JSC VN:HHP	N/A
Edelteq Holdings Berhad KLSE:0278	0.007x
Fine Blanking & Tool Co Ltd TWO:4535	0.036x
Wanshih Electronic Co Ltd TWO:6134	-0.054x
Cingulate Inc NASDAQ:CING	-1.434x

Annual Cash Flow Conversion Efficiency for AB Science S.A (2009–2025)

The table below shows the annual cash flow conversion efficiency of AB Science S.A from 2009 to 2025. Review AB free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-9.81 Million ≈ $-11.47 Million	€-4.29 Million ≈ $-5.01 Million	0.437x	+2077.17%
2024-12-31	€-23.75 Million ≈ $-27.77 Million	€525.00K ≈ $613.78K	-0.022x	-102.75%
2023-12-31	€-21.01 Million ≈ $-24.56 Million	€-16.87 Million ≈ $-19.72 Million	0.803x	+63.95%
2022-12-31	€-35.67 Million ≈ $-41.70 Million	€-17.47 Million ≈ $-20.43 Million	0.490x	-33.86%
2021-12-31	€-23.20 Million ≈ $-27.12 Million	€-17.18 Million ≈ $-20.08 Million	0.740x	+7.14%
2020-12-31	€-19.55 Million ≈ $-22.85 Million	€-13.51 Million ≈ $-15.80 Million	0.691x	+22.34%
2019-12-31	€-26.83 Million ≈ $-31.37 Million	€-15.16 Million ≈ $-17.72 Million	0.565x	-68.45%
2018-12-31	€-14.96 Million ≈ $-17.49 Million	€-26.79 Million ≈ $-31.32 Million	1.791x	+183.96%
2017-12-31	€10.73 Million ≈ $12.55 Million	€-22.90 Million ≈ $-26.77 Million	-2.133x	-129.94%
2016-12-31	€-4.71 Million ≈ $-5.50 Million	€-33.52 Million ≈ $-39.19 Million	7.124x	+431.03%
2015-12-31	€-17.26 Million ≈ $-20.18 Million	€-23.16 Million ≈ $-27.07 Million	1.342x	+48.59%
2014-12-31	€-15.68 Million ≈ $-18.33 Million	€-14.16 Million ≈ $-16.55 Million	0.903x	+102.40%
2013-12-31	€341.00K ≈ $398.66K	€-12.84 Million ≈ $-15.01 Million	-37.639x	-2868.84%
2012-12-31	€4.90 Million ≈ $5.73 Million	€-6.21 Million ≈ $-7.26 Million	-1.268x	-17.81%
2011-12-31	€7.73 Million ≈ $9.04 Million	€-8.32 Million ≈ $-9.73 Million	-1.076x	-102.33%
2010-12-31	€14.78 Million ≈ $17.28 Million	€-7.86 Million ≈ $-9.19 Million	-0.532x	+92.87%
2009-12-31	€1.04 Million ≈ $1.22 Million	€-7.77 Million ≈ $-9.08 Million	-7.460x	--

About AB Science S.A

PA:AB France Drug Manufacturers - Specialty & Generic

Market Cap

$61.05 Million

€52.22 Million EUR

Market Cap Rank

#20941 Global

#325 in France

Share Price

€0.54

Change (1 day)

-1.28%

52-Week Range

€0.51 - €1.54

All Time High

€20.15